SEC Company Response from INTELLIGENT BIO SOLUTIONS INC. (INBS) (CIK 0001725430) (INBS) — Aug 2, 2019
INTELLIGENT BIO SOLUTIONS INC. (INBS) (CIK 0001725430)
Date: Aug. 2, 2019 · CIK: 0001725430 · Accession: 0001493152-19-011561
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-232557
Referenced dates: July 11, 2019
Letter
Graubard Miller
The Chrysler Building
Lexington Avenue
New York, N.Y. 10174-1101
(212) 818-8800
facsimile
direct dial number
(212) 818-8881
(212) 818-8602
email address
eschwartz@graubard.com
August 2, 2019
Division of Corporation Finance
Office of Electronics and Machinery
Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Re: Glucose Biosensor Systems (Greater China) Holdings, Inc.
Registration Statement on Form S-1
Filed July 5, 2019
File No. 333-232557
Ladies and Gentlemen:
On behalf of Glucose Biosensor Systems (Greater China) Holdings, Inc. (the “Company”), we respond as follows to the Staff’s comment letter, dated July 11, 2019, relating to the above-captioned Registration Statement on Form S-1 (“Registration Statement”). Captions and page references herein correspond to those set forth in the amended filing of the Registration Statement, a copy of which has been marked with the changes from the prior filing of the Registration Statement.
Please note that for the Staff’s convenience, we have recited each of the Staff’s comments and provided the response to each comment immediately thereafter.
Registration Statement on Form S-1 filed July 5, 2019 Executive Compensation, page 70
1. Please update the disclosure in this section to be as of your most recently completed fiscal year, June 30, 2019, including all required tables.
The Company has revised the disclosure as requested on pages 70 and 71 of the Registration Statement.
Determination of Offering Price, page 86
2. We note your disclosure that there has been a “very limited public market” for your common stock. Revise to clarify where there has been a public market for your shares or revise as appropriate.
The Company has revised the disclosure as requested on page 87 of the Registration Statement, to clarify that there currently is no public market for its common stock.
*************
If you have any questions, please do not hesitate to contact me at the above telephone and facsimile numbers.
Sincerely,
/s/
Eric T. Schwartz
Show Raw Text
CORRESP
1
filename1.htm
Graubard
Miller
The
Chrysler Building
405
Lexington Avenue
New
York, N.Y. 10174-1101
(212)
818-8800
facsimile
direct
dial number
(212)
818-8881
(212)
818-8602
email
address
eschwartz@graubard.com
August
2, 2019
Division
of Corporation Finance
Office
of Electronics and Machinery
Securities
and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Glucose
Biosensor Systems (Greater China) Holdings, Inc.
Registration
Statement on Form S-1
Filed
July 5, 2019
File
No. 333-232557
Ladies
and Gentlemen:
On
behalf of Glucose Biosensor Systems (Greater China) Holdings, Inc. (the “Company”), we respond as follows to
the Staff’s comment letter, dated July 11, 2019, relating to the above-captioned Registration Statement on Form S-1 (“Registration
Statement”). Captions and page references herein correspond to those set forth in the amended filing of the Registration
Statement, a copy of which has been marked with the changes from the prior filing of the Registration Statement.
Please
note that for the Staff’s convenience, we have recited each of the Staff’s comments and provided the response to each
comment immediately thereafter.
Registration
Statement on Form S-1 filed July 5, 2019 Executive Compensation, page 70
1.
Please
update the disclosure in this section to be as of your most recently completed fiscal year, June 30, 2019, including all required
tables.
The
Company has revised the disclosure as requested on pages 70 and 71 of the Registration Statement.
Determination
of Offering Price, page 86
2.
We
note your disclosure that there has been a “very limited public market” for your common stock. Revise to clarify
where there has been a public market for your shares or revise as appropriate.
The
Company has revised the disclosure as requested on page 87 of the Registration Statement, to clarify that there currently
is no public market for its common stock.
*************
If
you have any questions, please do not hesitate to contact me at the above telephone and facsimile numbers.
Sincerely,
/s/
Eric T. Schwartz
Eric
T. Schwartz
cc:
Mr.
Harry Simeonidis
Spencer
G. Feldman, Esq.